VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129 | -100.0% | 29,778 | -70.7% | 0.00% | -100.0% |
| Q1 2022 | $1,151,000 | -72.3% | 101,763 | -61.5% | 0.00% | -80.0% |
| Q4 2021 | $4,150,000 | -29.3% | 264,529 | -22.7% | 0.01% | -28.6% |
| Q3 2021 | $5,866,000 | -35.3% | 342,243 | -18.8% | 0.01% | -36.4% |
| Q2 2021 | $9,065,000 | +837.4% | 421,422 | +701.8% | 0.01% | +450.0% |
| Q1 2019 | $967,000 | -20.0% | 52,559 | -39.2% | 0.00% | -50.0% |
| Q1 2017 | $1,209,000 | – | 86,389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |